Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation and pain, accompanied by symptoms like weakness, fever, and fatigue. This chronic inflammatory disorder extends beyond joints, impacting various body tissues. The immune system’s misguided attack on these tissues leads to pain, swelling, and deformity. Mayo Clinic provides insights into the symptoms, causes, diagnosis, and treatment of rheumatoid arthritis.
Arthritis encompasses roughly 100 conditions affecting joints and surrounding tissues. Without proper management, arthritis can lead to severe pain, activity limitations, and disability. Adults with arthritis often experience heightened rates of anxiety and depression and constituted a significant portion of prescription opioid users in the United States in 2015.
There’s a genetic predisposition to rheumatoid arthritis, yet many at risk remain unaware of their susceptibility to severe forms of the disease. RA primarily affects joints, causing warmth, swelling, and pain, often worsening after rest. It frequently involves the wrists and hands, typically affecting both sides of the body. RA can also impact skin, eyes, lungs, and other body parts.
The main symptoms of arthritis include joint pain and stiffness, which usually intensify with age. The most prevalent forms are osteoarthritis and rheumatoid arthritis. Osteoarthritis involves the breakdown of cartilage at joint ends, while rheumatoid arthritis is an autoimmune disease affecting joints.
Silo Pharma’s SPU-21 Peptide has shown positive results in inhibiting the progression of rheumatoid arthritis. This study aimed to further explore the patented SPU-21’s efficacy.
For better understanding and management of RA, including sleep positions and tips for improved rest, visit Healthline’s guide on rheumatoid arthritis sleep positions. Learn more about the disease from Mayo Clinic. Explore the prevalence of diagnosed arthritis in the United States (2019–2021), and discover the link between gut bacteria and pre-rheumatoid arthritis identified by Mayo Clinic researchers here. For a comprehensive understanding of rheumatoid arthritis, visit its Wikipedia page and Mayo Clinic’s overview of arthritis symptoms and causes. Read about Silo Pharma’s breakthrough with SPU-21 Peptide.
